Remove BioTech Remove Efficiency Remove Strategy
article thumbnail

The Financialization of Disruptive Technology

The Agile Manager

What if this is not a viable strategy? A recent FT Lex article on biotech investing drives the point home: "A 20-year study found only one-fifth of exits were profitable. Every day you're in business is a day you're able to bring the fight, and this is simply the new way of bringing the fight. Better figure it out.